Oxford BioMedica Company
25+ years enabling the world’s most progressive and successful viral vector therapies. Full service offering, supported by robust quality systems.
Founded Date:
1995
Last Funding Type:
Grant
Headquarters:
Oxford, Oxfordshire, United Kingdom
Investors Number:
1
Technology:
Others
Employee Number:
51-100
Industry:
Gene Therapy
Estimated Revenue:
$10M to $50M
Number Of Exists:
Grant
Funding Status:
M&A
Investor Type:
Company
Investment Stage:
N/A
Total Funding:
£12.3M